45
Growth Score in past quarter
pts
Heat Score 45 in past quarter
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
3036123
Connecting the regenerative medicine community to the standards development process.
- Michael Mendicino: Co-Founder and Board Member
- April Lynch: Secretary, Executive Committee and Board of Directors Member
About the Company
The Standards Coordinating Body for Gene, Cell, and Regenerative Medicines and Cell-Based Drug Discovery (SCB) is a non-profit organization that connects the regenerative medicine community to the standards development process. With stakeholders from industry, academia, professional societies, and government entities, SCB occupies a unique niche
within the regenerative medicine ecosystem and has no vested interests in a particular scientific, commercial, clinical, or policy approach. Our goal is to address stakeholder needs and support the advancement of standards that enhance the entire regenerative medicine community and accelerate innovation.